Status:
COMPLETED
Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor)
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Benign Neuronal Desease
Eligibility:
All Genders
18+ years
Brief Summary
Differential diagnoses of MVNT include DNT (dysembryoplastic neuroepithelial tumor), low-grade gliomas, cortical dysplasias or even hamartomas.
Detailed Description
Differential diagnoses of MVNT include DNT (dysembryoplastic neuroepithelial tumor), low-grade gliomas, cortical dysplasias or even hamartomas. However, in order to avoid an invasive surgical procedu...
Eligibility Criteria
Inclusion
- Patient over 18 years old
- Suspicion of MVNT on an MRI: it is considered that it will be necessary at least the 2 major criteria associated with at least 1 minor criterion to enter the definition of suspicion of MVNT:
- Major criteria:
- Multinodular aspect in cluster
- High FLAIR hypersignal / T2
- Minor criteria:
- Absence of mass effect
- Hyposignal T1
- Center of the lesion in hypsignal FLAIR or T1 hypersignal
- Affiliate or beneficiary of a Social Security scheme
- Having received informed information about the study and consenting to participate in the study
Exclusion
- Patient benefiting from a legal protection measure
- Pregnant or lactating woman
- Contraindication to MRI
Key Trial Info
Start Date :
December 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2025
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04103190
Start Date
December 10 2019
End Date
July 10 2025
Last Update
January 5 2026
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Pellegrin
Bordeaux, Bordeaux, France, 33076
2
Fondation Adolphe de Rothschild
Paris, PARIS, France, 75019
3
CHU Rennes
Rennes, Rennes, France, 35033
4
CHU de Rouen
Rouen, Rouen, France, 76000